CANCER GENE THERAPY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2168724, encodeId=fd662168e24de, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志选择非OA 仍需要处理费吗？Cancer Gene Therapy levies a fixed page charge of US$236/£143 per typeset page, which is fully inclusive of color reproduction of all color images in print, HTML, and PDF formats. If applicable, 20% VAT will be added to the total page charge amount upon invoicing. This also applies to all EU authors who do not provide a valid VAT number upon returning their form., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=摩西, createdTime=Wed Nov 15 21:57:15 CST 2023, time=2023-11-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144781, encodeId=0a932144e81fc, content=2022.11.28投稿，2023.06.21接收，中间经历了三次修稿，第一次一位审稿人提议接收，一位审稿人提了3个意见，第二次又邀请了一位审稿人，提了4个意见，第一次的审稿人提了一些意见，但都比较友好。第三次就是暂时接收然后修回，过了一个月后正式接收。总体来说期刊还是比较慢的，但按照要求修下来应该不会有什么问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=629e5549714, createdName=ms8000000927816250, createdTime=Mon Jun 26 11:22:03 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1224823, encodeId=e7a9122482338, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤基础研究 经验分享：需提供WB原始条带，qPCR原始CT值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6db75641421, createdName=ms8000001211461628, createdTime=Mon Jun 06 21:27:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577517, encodeId=5d395e75176c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：刚刚在线发表了一篇，推荐给大家。 近几年IF年年涨，希望明年破5分。 小众期刊，nature小子刊，应该还处于成长阶段，年发表论著不超过100篇。 2019.06.25投稿，2019.07.12返回一审意见，2019.08.05补实验修回，2019.08.19接收，2019.10.08在线发表。整个投稿过程可以说非常愉快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43892023685, createdName=童话1024, createdTime=Tue Oct 08 21:18:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236587, encodeId=1081123658ebd, content=请问生信友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58bd5308246, createdName=归浆, createdTime=Thu Aug 04 15:10:35 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230117, encodeId=40b7123011ec2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：纯生信，1周拒绝，建议转投scientific reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287a5607334, createdName=qiuqiu96, createdTime=Sat Jul 02 12:14:38 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223150, encodeId=6a5e12231505f, content=评审专家很认真但是有一些专家可能处于起步阶段提出的建议偶有奇葩比如明显用语言语法编辑软件通看全文什么意见都不提专门挑和他意见相左的词汇进行举例，没有具体去看作者提及的科学问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cda1660169, createdName=Neville Wang, createdTime=Sun May 29 13:32:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088391, encodeId=0ff1108839136, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088392, encodeId=62191088392b1, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078460, encodeId=943b10e8460a3, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ddc6155468, createdName=ms8000001227904366, createdTime=Thu Dec 09 16:10:47 CST 2021, time=2021-12-09, status=1, ipAttribution=)]

2023-11-15 摩西来自河南省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：这个杂志选择非OA 仍需要处理费吗？Cancer Gene Therapy levies a fixed page charge of US$236/£143 per typeset page, which is fully inclusive of color reproduction of all color images in print, HTML, and PDF formats. If applicable, 20% VAT will be added to the total page charge amount upon invoicing. This also applies to all EU authors who do not provide a valid VAT number upon returning their form.

59 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168724, encodeId=fd662168e24de, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志选择非OA 仍需要处理费吗？Cancer Gene Therapy levies a fixed page charge of US$236/£143 per typeset page, which is fully inclusive of color reproduction of all color images in print, HTML, and PDF formats. If applicable, 20% VAT will be added to the total page charge amount upon invoicing. This also applies to all EU authors who do not provide a valid VAT number upon returning their form., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=摩西, createdTime=Wed Nov 15 21:57:15 CST 2023, time=2023-11-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144781, encodeId=0a932144e81fc, content=2022.11.28投稿，2023.06.21接收，中间经历了三次修稿，第一次一位审稿人提议接收，一位审稿人提了3个意见，第二次又邀请了一位审稿人，提了4个意见，第一次的审稿人提了一些意见，但都比较友好。第三次就是暂时接收然后修回，过了一个月后正式接收。总体来说期刊还是比较慢的，但按照要求修下来应该不会有什么问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=629e5549714, createdName=ms8000000927816250, createdTime=Mon Jun 26 11:22:03 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1224823, encodeId=e7a9122482338, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤基础研究 经验分享：需提供WB原始条带，qPCR原始CT值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6db75641421, createdName=ms8000001211461628, createdTime=Mon Jun 06 21:27:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577517, encodeId=5d395e75176c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：刚刚在线发表了一篇，推荐给大家。 近几年IF年年涨，希望明年破5分。 小众期刊，nature小子刊，应该还处于成长阶段，年发表论著不超过100篇。 2019.06.25投稿，2019.07.12返回一审意见，2019.08.05补实验修回，2019.08.19接收，2019.10.08在线发表。整个投稿过程可以说非常愉快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43892023685, createdName=童话1024, createdTime=Tue Oct 08 21:18:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236587, encodeId=1081123658ebd, content=请问生信友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58bd5308246, createdName=归浆, createdTime=Thu Aug 04 15:10:35 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230117, encodeId=40b7123011ec2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：纯生信，1周拒绝，建议转投scientific reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287a5607334, createdName=qiuqiu96, createdTime=Sat Jul 02 12:14:38 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223150, encodeId=6a5e12231505f, content=评审专家很认真但是有一些专家可能处于起步阶段提出的建议偶有奇葩比如明显用语言语法编辑软件通看全文什么意见都不提专门挑和他意见相左的词汇进行举例，没有具体去看作者提及的科学问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cda1660169, createdName=Neville Wang, createdTime=Sun May 29 13:32:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088391, encodeId=0ff1108839136, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088392, encodeId=62191088392b1, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078460, encodeId=943b10e8460a3, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ddc6155468, createdName=ms8000001227904366, createdTime=Thu Dec 09 16:10:47 CST 2021, time=2021-12-09, status=1, ipAttribution=)]

2023-06-26 ms8000000927816250 来自上海

2022.11.28投稿，2023.06.21接收，中间经历了三次修稿，第一次一位审稿人提议接收，一位审稿人提了3个意见，第二次又邀请了一位审稿人，提了4个意见，第一次的审稿人提了一些意见，但都比较友好。第三次就是暂时接收然后修回，过了一个月后正式接收。总体来说期刊还是比较慢的，但按照要求修下来应该不会有什么问题。

126 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168724, encodeId=fd662168e24de, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志选择非OA 仍需要处理费吗？Cancer Gene Therapy levies a fixed page charge of US$236/£143 per typeset page, which is fully inclusive of color reproduction of all color images in print, HTML, and PDF formats. If applicable, 20% VAT will be added to the total page charge amount upon invoicing. This also applies to all EU authors who do not provide a valid VAT number upon returning their form., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=摩西, createdTime=Wed Nov 15 21:57:15 CST 2023, time=2023-11-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144781, encodeId=0a932144e81fc, content=2022.11.28投稿，2023.06.21接收，中间经历了三次修稿，第一次一位审稿人提议接收，一位审稿人提了3个意见，第二次又邀请了一位审稿人，提了4个意见，第一次的审稿人提了一些意见，但都比较友好。第三次就是暂时接收然后修回，过了一个月后正式接收。总体来说期刊还是比较慢的，但按照要求修下来应该不会有什么问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=629e5549714, createdName=ms8000000927816250, createdTime=Mon Jun 26 11:22:03 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1224823, encodeId=e7a9122482338, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤基础研究 经验分享：需提供WB原始条带，qPCR原始CT值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6db75641421, createdName=ms8000001211461628, createdTime=Mon Jun 06 21:27:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577517, encodeId=5d395e75176c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：刚刚在线发表了一篇，推荐给大家。 近几年IF年年涨，希望明年破5分。 小众期刊，nature小子刊，应该还处于成长阶段，年发表论著不超过100篇。 2019.06.25投稿，2019.07.12返回一审意见，2019.08.05补实验修回，2019.08.19接收，2019.10.08在线发表。整个投稿过程可以说非常愉快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43892023685, createdName=童话1024, createdTime=Tue Oct 08 21:18:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236587, encodeId=1081123658ebd, content=请问生信友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58bd5308246, createdName=归浆, createdTime=Thu Aug 04 15:10:35 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230117, encodeId=40b7123011ec2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：纯生信，1周拒绝，建议转投scientific reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287a5607334, createdName=qiuqiu96, createdTime=Sat Jul 02 12:14:38 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223150, encodeId=6a5e12231505f, content=评审专家很认真但是有一些专家可能处于起步阶段提出的建议偶有奇葩比如明显用语言语法编辑软件通看全文什么意见都不提专门挑和他意见相左的词汇进行举例，没有具体去看作者提及的科学问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cda1660169, createdName=Neville Wang, createdTime=Sun May 29 13:32:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088391, encodeId=0ff1108839136, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088392, encodeId=62191088392b1, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078460, encodeId=943b10e8460a3, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ddc6155468, createdName=ms8000001227904366, createdTime=Thu Dec 09 16:10:47 CST 2021, time=2021-12-09, status=1, ipAttribution=)]

2022-06-06 ms8000001211461628

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤基础研究
经验分享：需提供WB原始条带，qPCR原始CT值

95 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168724, encodeId=fd662168e24de, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志选择非OA 仍需要处理费吗？Cancer Gene Therapy levies a fixed page charge of US$236/£143 per typeset page, which is fully inclusive of color reproduction of all color images in print, HTML, and PDF formats. If applicable, 20% VAT will be added to the total page charge amount upon invoicing. This also applies to all EU authors who do not provide a valid VAT number upon returning their form., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=摩西, createdTime=Wed Nov 15 21:57:15 CST 2023, time=2023-11-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144781, encodeId=0a932144e81fc, content=2022.11.28投稿，2023.06.21接收，中间经历了三次修稿，第一次一位审稿人提议接收，一位审稿人提了3个意见，第二次又邀请了一位审稿人，提了4个意见，第一次的审稿人提了一些意见，但都比较友好。第三次就是暂时接收然后修回，过了一个月后正式接收。总体来说期刊还是比较慢的，但按照要求修下来应该不会有什么问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=629e5549714, createdName=ms8000000927816250, createdTime=Mon Jun 26 11:22:03 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1224823, encodeId=e7a9122482338, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤基础研究 经验分享：需提供WB原始条带，qPCR原始CT值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6db75641421, createdName=ms8000001211461628, createdTime=Mon Jun 06 21:27:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577517, encodeId=5d395e75176c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：刚刚在线发表了一篇，推荐给大家。 近几年IF年年涨，希望明年破5分。 小众期刊，nature小子刊，应该还处于成长阶段，年发表论著不超过100篇。 2019.06.25投稿，2019.07.12返回一审意见，2019.08.05补实验修回，2019.08.19接收，2019.10.08在线发表。整个投稿过程可以说非常愉快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43892023685, createdName=童话1024, createdTime=Tue Oct 08 21:18:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236587, encodeId=1081123658ebd, content=请问生信友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58bd5308246, createdName=归浆, createdTime=Thu Aug 04 15:10:35 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230117, encodeId=40b7123011ec2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：纯生信，1周拒绝，建议转投scientific reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287a5607334, createdName=qiuqiu96, createdTime=Sat Jul 02 12:14:38 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223150, encodeId=6a5e12231505f, content=评审专家很认真但是有一些专家可能处于起步阶段提出的建议偶有奇葩比如明显用语言语法编辑软件通看全文什么意见都不提专门挑和他意见相左的词汇进行举例，没有具体去看作者提及的科学问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cda1660169, createdName=Neville Wang, createdTime=Sun May 29 13:32:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088391, encodeId=0ff1108839136, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088392, encodeId=62191088392b1, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078460, encodeId=943b10e8460a3, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ddc6155468, createdName=ms8000001227904366, createdTime=Thu Dec 09 16:10:47 CST 2021, time=2021-12-09, status=1, ipAttribution=)]

2019-10-08 童话1024

审稿速度:1.0 | 投稿命中率:50.0
经验分享：刚刚在线发表了一篇，推荐给大家。
近几年IF年年涨，希望明年破5分。
小众期刊，nature小子刊，应该还处于成长阶段，年发表论著不超过100篇。
2019.06.25投稿，2019.07.12返回一审意见，2019.08.05补实验修回，2019.08.19接收，2019.10.08在线发表。整个投稿过程可以说非常愉快。

219 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168724, encodeId=fd662168e24de, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志选择非OA 仍需要处理费吗？Cancer Gene Therapy levies a fixed page charge of US$236/£143 per typeset page, which is fully inclusive of color reproduction of all color images in print, HTML, and PDF formats. If applicable, 20% VAT will be added to the total page charge amount upon invoicing. This also applies to all EU authors who do not provide a valid VAT number upon returning their form., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=摩西, createdTime=Wed Nov 15 21:57:15 CST 2023, time=2023-11-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144781, encodeId=0a932144e81fc, content=2022.11.28投稿，2023.06.21接收，中间经历了三次修稿，第一次一位审稿人提议接收，一位审稿人提了3个意见，第二次又邀请了一位审稿人，提了4个意见，第一次的审稿人提了一些意见，但都比较友好。第三次就是暂时接收然后修回，过了一个月后正式接收。总体来说期刊还是比较慢的，但按照要求修下来应该不会有什么问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=629e5549714, createdName=ms8000000927816250, createdTime=Mon Jun 26 11:22:03 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1224823, encodeId=e7a9122482338, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤基础研究 经验分享：需提供WB原始条带，qPCR原始CT值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6db75641421, createdName=ms8000001211461628, createdTime=Mon Jun 06 21:27:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577517, encodeId=5d395e75176c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：刚刚在线发表了一篇，推荐给大家。 近几年IF年年涨，希望明年破5分。 小众期刊，nature小子刊，应该还处于成长阶段，年发表论著不超过100篇。 2019.06.25投稿，2019.07.12返回一审意见，2019.08.05补实验修回，2019.08.19接收，2019.10.08在线发表。整个投稿过程可以说非常愉快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43892023685, createdName=童话1024, createdTime=Tue Oct 08 21:18:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236587, encodeId=1081123658ebd, content=请问生信友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58bd5308246, createdName=归浆, createdTime=Thu Aug 04 15:10:35 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230117, encodeId=40b7123011ec2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：纯生信，1周拒绝，建议转投scientific reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287a5607334, createdName=qiuqiu96, createdTime=Sat Jul 02 12:14:38 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223150, encodeId=6a5e12231505f, content=评审专家很认真但是有一些专家可能处于起步阶段提出的建议偶有奇葩比如明显用语言语法编辑软件通看全文什么意见都不提专门挑和他意见相左的词汇进行举例，没有具体去看作者提及的科学问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cda1660169, createdName=Neville Wang, createdTime=Sun May 29 13:32:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088391, encodeId=0ff1108839136, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088392, encodeId=62191088392b1, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078460, encodeId=943b10e8460a3, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ddc6155468, createdName=ms8000001227904366, createdTime=Thu Dec 09 16:10:47 CST 2021, time=2021-12-09, status=1, ipAttribution=)]

2022-08-04 归浆

请问生信友好吗

96 0

[GetPortalCommentsPageByObjectIdResponse(id=2168724, encodeId=fd662168e24de, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志选择非OA 仍需要处理费吗？Cancer Gene Therapy levies a fixed page charge of US$236/£143 per typeset page, which is fully inclusive of color reproduction of all color images in print, HTML, and PDF formats. If applicable, 20% VAT will be added to the total page charge amount upon invoicing. This also applies to all EU authors who do not provide a valid VAT number upon returning their form., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=摩西, createdTime=Wed Nov 15 21:57:15 CST 2023, time=2023-11-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144781, encodeId=0a932144e81fc, content=2022.11.28投稿，2023.06.21接收，中间经历了三次修稿，第一次一位审稿人提议接收，一位审稿人提了3个意见，第二次又邀请了一位审稿人，提了4个意见，第一次的审稿人提了一些意见，但都比较友好。第三次就是暂时接收然后修回，过了一个月后正式接收。总体来说期刊还是比较慢的，但按照要求修下来应该不会有什么问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=629e5549714, createdName=ms8000000927816250, createdTime=Mon Jun 26 11:22:03 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1224823, encodeId=e7a9122482338, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤基础研究 经验分享：需提供WB原始条带，qPCR原始CT值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6db75641421, createdName=ms8000001211461628, createdTime=Mon Jun 06 21:27:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577517, encodeId=5d395e75176c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：刚刚在线发表了一篇，推荐给大家。 近几年IF年年涨，希望明年破5分。 小众期刊，nature小子刊，应该还处于成长阶段，年发表论著不超过100篇。 2019.06.25投稿，2019.07.12返回一审意见，2019.08.05补实验修回，2019.08.19接收，2019.10.08在线发表。整个投稿过程可以说非常愉快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43892023685, createdName=童话1024, createdTime=Tue Oct 08 21:18:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236587, encodeId=1081123658ebd, content=请问生信友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58bd5308246, createdName=归浆, createdTime=Thu Aug 04 15:10:35 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230117, encodeId=40b7123011ec2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：纯生信，1周拒绝，建议转投scientific reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287a5607334, createdName=qiuqiu96, createdTime=Sat Jul 02 12:14:38 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223150, encodeId=6a5e12231505f, content=评审专家很认真但是有一些专家可能处于起步阶段提出的建议偶有奇葩比如明显用语言语法编辑软件通看全文什么意见都不提专门挑和他意见相左的词汇进行举例，没有具体去看作者提及的科学问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cda1660169, createdName=Neville Wang, createdTime=Sun May 29 13:32:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088391, encodeId=0ff1108839136, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088392, encodeId=62191088392b1, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078460, encodeId=943b10e8460a3, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ddc6155468, createdName=ms8000001227904366, createdTime=Thu Dec 09 16:10:47 CST 2021, time=2021-12-09, status=1, ipAttribution=)]

2022-07-02 qiuqiu96

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;生信
经验分享：纯生信，1周拒绝，建议转投scientific reports

93 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168724, encodeId=fd662168e24de, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志选择非OA 仍需要处理费吗？Cancer Gene Therapy levies a fixed page charge of US$236/£143 per typeset page, which is fully inclusive of color reproduction of all color images in print, HTML, and PDF formats. If applicable, 20% VAT will be added to the total page charge amount upon invoicing. This also applies to all EU authors who do not provide a valid VAT number upon returning their form., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=摩西, createdTime=Wed Nov 15 21:57:15 CST 2023, time=2023-11-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144781, encodeId=0a932144e81fc, content=2022.11.28投稿，2023.06.21接收，中间经历了三次修稿，第一次一位审稿人提议接收，一位审稿人提了3个意见，第二次又邀请了一位审稿人，提了4个意见，第一次的审稿人提了一些意见，但都比较友好。第三次就是暂时接收然后修回，过了一个月后正式接收。总体来说期刊还是比较慢的，但按照要求修下来应该不会有什么问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=629e5549714, createdName=ms8000000927816250, createdTime=Mon Jun 26 11:22:03 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1224823, encodeId=e7a9122482338, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤基础研究 经验分享：需提供WB原始条带，qPCR原始CT值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6db75641421, createdName=ms8000001211461628, createdTime=Mon Jun 06 21:27:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577517, encodeId=5d395e75176c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：刚刚在线发表了一篇，推荐给大家。 近几年IF年年涨，希望明年破5分。 小众期刊，nature小子刊，应该还处于成长阶段，年发表论著不超过100篇。 2019.06.25投稿，2019.07.12返回一审意见，2019.08.05补实验修回，2019.08.19接收，2019.10.08在线发表。整个投稿过程可以说非常愉快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43892023685, createdName=童话1024, createdTime=Tue Oct 08 21:18:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236587, encodeId=1081123658ebd, content=请问生信友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58bd5308246, createdName=归浆, createdTime=Thu Aug 04 15:10:35 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230117, encodeId=40b7123011ec2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：纯生信，1周拒绝，建议转投scientific reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287a5607334, createdName=qiuqiu96, createdTime=Sat Jul 02 12:14:38 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223150, encodeId=6a5e12231505f, content=评审专家很认真但是有一些专家可能处于起步阶段提出的建议偶有奇葩比如明显用语言语法编辑软件通看全文什么意见都不提专门挑和他意见相左的词汇进行举例，没有具体去看作者提及的科学问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cda1660169, createdName=Neville Wang, createdTime=Sun May 29 13:32:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088391, encodeId=0ff1108839136, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088392, encodeId=62191088392b1, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078460, encodeId=943b10e8460a3, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ddc6155468, createdName=ms8000001227904366, createdTime=Thu Dec 09 16:10:47 CST 2021, time=2021-12-09, status=1, ipAttribution=)]

2022-05-29 Neville Wang

评审专家很认真但是有一些专家可能处于起步阶段提出的建议偶有奇葩比如明显用语言语法编辑软件通看全文什么意见都不提专门挑和他意见相左的词汇进行举例，没有具体去看作者提及的科学问题。

96 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168724, encodeId=fd662168e24de, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志选择非OA 仍需要处理费吗？Cancer Gene Therapy levies a fixed page charge of US$236/£143 per typeset page, which is fully inclusive of color reproduction of all color images in print, HTML, and PDF formats. If applicable, 20% VAT will be added to the total page charge amount upon invoicing. This also applies to all EU authors who do not provide a valid VAT number upon returning their form., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=摩西, createdTime=Wed Nov 15 21:57:15 CST 2023, time=2023-11-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144781, encodeId=0a932144e81fc, content=2022.11.28投稿，2023.06.21接收，中间经历了三次修稿，第一次一位审稿人提议接收，一位审稿人提了3个意见，第二次又邀请了一位审稿人，提了4个意见，第一次的审稿人提了一些意见，但都比较友好。第三次就是暂时接收然后修回，过了一个月后正式接收。总体来说期刊还是比较慢的，但按照要求修下来应该不会有什么问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=629e5549714, createdName=ms8000000927816250, createdTime=Mon Jun 26 11:22:03 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1224823, encodeId=e7a9122482338, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤基础研究 经验分享：需提供WB原始条带，qPCR原始CT值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6db75641421, createdName=ms8000001211461628, createdTime=Mon Jun 06 21:27:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577517, encodeId=5d395e75176c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：刚刚在线发表了一篇，推荐给大家。 近几年IF年年涨，希望明年破5分。 小众期刊，nature小子刊，应该还处于成长阶段，年发表论著不超过100篇。 2019.06.25投稿，2019.07.12返回一审意见，2019.08.05补实验修回，2019.08.19接收，2019.10.08在线发表。整个投稿过程可以说非常愉快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43892023685, createdName=童话1024, createdTime=Tue Oct 08 21:18:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236587, encodeId=1081123658ebd, content=请问生信友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58bd5308246, createdName=归浆, createdTime=Thu Aug 04 15:10:35 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230117, encodeId=40b7123011ec2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：纯生信，1周拒绝，建议转投scientific reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287a5607334, createdName=qiuqiu96, createdTime=Sat Jul 02 12:14:38 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223150, encodeId=6a5e12231505f, content=评审专家很认真但是有一些专家可能处于起步阶段提出的建议偶有奇葩比如明显用语言语法编辑软件通看全文什么意见都不提专门挑和他意见相左的词汇进行举例，没有具体去看作者提及的科学问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cda1660169, createdName=Neville Wang, createdTime=Sun May 29 13:32:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088391, encodeId=0ff1108839136, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088392, encodeId=62191088392b1, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078460, encodeId=943b10e8460a3, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ddc6155468, createdName=ms8000001227904366, createdTime=Thu Dec 09 16:10:47 CST 2021, time=2021-12-09, status=1, ipAttribution=)]

2021-12-28 乌云背后的幸福线

如果文章发表了未提供ORCIDID如何添加？

103 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168724, encodeId=fd662168e24de, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志选择非OA 仍需要处理费吗？Cancer Gene Therapy levies a fixed page charge of US$236/£143 per typeset page, which is fully inclusive of color reproduction of all color images in print, HTML, and PDF formats. If applicable, 20% VAT will be added to the total page charge amount upon invoicing. This also applies to all EU authors who do not provide a valid VAT number upon returning their form., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=摩西, createdTime=Wed Nov 15 21:57:15 CST 2023, time=2023-11-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144781, encodeId=0a932144e81fc, content=2022.11.28投稿，2023.06.21接收，中间经历了三次修稿，第一次一位审稿人提议接收，一位审稿人提了3个意见，第二次又邀请了一位审稿人，提了4个意见，第一次的审稿人提了一些意见，但都比较友好。第三次就是暂时接收然后修回，过了一个月后正式接收。总体来说期刊还是比较慢的，但按照要求修下来应该不会有什么问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=629e5549714, createdName=ms8000000927816250, createdTime=Mon Jun 26 11:22:03 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1224823, encodeId=e7a9122482338, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤基础研究 经验分享：需提供WB原始条带，qPCR原始CT值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6db75641421, createdName=ms8000001211461628, createdTime=Mon Jun 06 21:27:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577517, encodeId=5d395e75176c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：刚刚在线发表了一篇，推荐给大家。 近几年IF年年涨，希望明年破5分。 小众期刊，nature小子刊，应该还处于成长阶段，年发表论著不超过100篇。 2019.06.25投稿，2019.07.12返回一审意见，2019.08.05补实验修回，2019.08.19接收，2019.10.08在线发表。整个投稿过程可以说非常愉快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43892023685, createdName=童话1024, createdTime=Tue Oct 08 21:18:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236587, encodeId=1081123658ebd, content=请问生信友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58bd5308246, createdName=归浆, createdTime=Thu Aug 04 15:10:35 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230117, encodeId=40b7123011ec2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：纯生信，1周拒绝，建议转投scientific reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287a5607334, createdName=qiuqiu96, createdTime=Sat Jul 02 12:14:38 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223150, encodeId=6a5e12231505f, content=评审专家很认真但是有一些专家可能处于起步阶段提出的建议偶有奇葩比如明显用语言语法编辑软件通看全文什么意见都不提专门挑和他意见相左的词汇进行举例，没有具体去看作者提及的科学问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cda1660169, createdName=Neville Wang, createdTime=Sun May 29 13:32:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088391, encodeId=0ff1108839136, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088392, encodeId=62191088392b1, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078460, encodeId=943b10e8460a3, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ddc6155468, createdName=ms8000001227904366, createdTime=Thu Dec 09 16:10:47 CST 2021, time=2021-12-09, status=1, ipAttribution=)]

2021-12-27 衣谷

什么是SCI？

90 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2168724, encodeId=fd662168e24de, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志选择非OA 仍需要处理费吗？Cancer Gene Therapy levies a fixed page charge of US$236/£143 per typeset page, which is fully inclusive of color reproduction of all color images in print, HTML, and PDF formats. If applicable, 20% VAT will be added to the total page charge amount upon invoicing. This also applies to all EU authors who do not provide a valid VAT number upon returning their form., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0b2f5139920, createdName=摩西, createdTime=Wed Nov 15 21:57:15 CST 2023, time=2023-11-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2144781, encodeId=0a932144e81fc, content=2022.11.28投稿，2023.06.21接收，中间经历了三次修稿，第一次一位审稿人提议接收，一位审稿人提了3个意见，第二次又邀请了一位审稿人，提了4个意见，第一次的审稿人提了一些意见，但都比较友好。第三次就是暂时接收然后修回，过了一个月后正式接收。总体来说期刊还是比较慢的，但按照要求修下来应该不会有什么问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=629e5549714, createdName=ms8000000927816250, createdTime=Mon Jun 26 11:22:03 CST 2023, time=2023-06-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1224823, encodeId=e7a9122482338, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤基础研究 经验分享：需提供WB原始条带，qPCR原始CT值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6db75641421, createdName=ms8000001211461628, createdTime=Mon Jun 06 21:27:03 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577517, encodeId=5d395e75176c, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：刚刚在线发表了一篇，推荐给大家。 近几年IF年年涨，希望明年破5分。 小众期刊，nature小子刊，应该还处于成长阶段，年发表论著不超过100篇。 2019.06.25投稿，2019.07.12返回一审意见，2019.08.05补实验修回，2019.08.19接收，2019.10.08在线发表。整个投稿过程可以说非常愉快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43892023685, createdName=童话1024, createdTime=Tue Oct 08 21:18:00 CST 2019, time=2019-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236587, encodeId=1081123658ebd, content=请问生信友好吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58bd5308246, createdName=归浆, createdTime=Thu Aug 04 15:10:35 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230117, encodeId=40b7123011ec2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;生信 经验分享：纯生信，1周拒绝，建议转投scientific reports, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=287a5607334, createdName=qiuqiu96, createdTime=Sat Jul 02 12:14:38 CST 2022, time=2022-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223150, encodeId=6a5e12231505f, content=评审专家很认真但是有一些专家可能处于起步阶段提出的建议偶有奇葩比如明显用语言语法编辑软件通看全文什么意见都不提专门挑和他意见相左的词汇进行举例，没有具体去看作者提及的科学问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cda1660169, createdName=Neville Wang, createdTime=Sun May 29 13:32:16 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088391, encodeId=0ff1108839136, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088392, encodeId=62191088392b1, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078460, encodeId=943b10e8460a3, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ddc6155468, createdName=ms8000001227904366, createdTime=Thu Dec 09 16:10:47 CST 2021, time=2021-12-09, status=1, ipAttribution=)]

2021-12-09 ms8000001227904366

无

105 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务